BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36685592)

  • 21. CCL2/CCR2 signaling pathway in glioblastoma multiforme.
    Vakilian A; Khorramdelazad H; Heidari P; Sheikh Rezaei Z; Hassanshahi G
    Neurochem Int; 2017 Feb; 103():1-7. PubMed ID: 28025034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.
    Chen Z; Feng X; Herting CJ; Garcia VA; Nie K; Pong WW; Rasmussen R; Dwivedi B; Seby S; Wolf SA; Gutmann DH; Hambardzumyan D
    Cancer Res; 2017 May; 77(9):2266-2278. PubMed ID: 28235764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer.
    Ren X; Xiao J; Zhang W; Wang F; Yan Y; Wu X; Zeng Z; He Y; Yang W; Liao W; Ding Y; Liang L
    Cell Death Dis; 2021 May; 12(5):484. PubMed ID: 33986252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.
    Kwack KH; Zhang L; Kramer ED; Thiyagarajan R; Lamb NA; Arao Y; Bard JE; Seldeen KL; Troen BR; Blackshear PJ; Abrams SI; Kirkwood KL
    Front Immunol; 2022; 13():1002163. PubMed ID: 36263047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.
    Yuanyuan L; Yakun L; Zhongyao L; Le Y; Weisong D; Moran G; Hui B; Chunyan L
    Exp Cell Res; 2021 Feb; 399(2):112467. PubMed ID: 33428904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LDK378 inhibits the recruitment of myeloid-derived suppressor cells to spleen via the p38-GRK2-CCR2 pathway in mice with sepsis.
    Hu J; Zhang W; Liu Y; Yang Y; Tan C; Wei X; Wang Y; Tan S; Liu M; Liu K; Liu Y; Zhang H; Xiao X
    Immunol Cell Biol; 2019 Nov; 97(10):902-915. PubMed ID: 31472096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
    Zhang J; Sarkar S; Cua R; Zhou Y; Hader W; Yong VW
    Carcinogenesis; 2012 Feb; 33(2):312-9. PubMed ID: 22159219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine CCL7 mediates trigeminal neuropathic pain
    Zhu LP; Xu ML; Yuan BT; Ma LJ; Gao YJ
    Mol Pain; 2023; 19():17448069231169373. PubMed ID: 36998150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
    Xiang H; Ramil CP; Hai J; Zhang C; Wang H; Watkins AA; Afshar R; Georgiev P; Sze MA; Song XS; Curran PJ; Cheng M; Miller JR; Sun D; Loboda A; Jia Y; Moy LY; Chi A; Brandish PE
    Cancer Immunol Res; 2020 Apr; 8(4):436-450. PubMed ID: 32075803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal Stroke and TLR1/2 Ligand Recruit Myeloid Cells through the Choroid Plexus in a CX3CR1-CCR2- and Context-Specific Manner.
    Rayasam A; Faustino J; Lecuyer M; Vexler ZS
    J Neurosci; 2020 May; 40(19):3849-3861. PubMed ID: 32269105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
    Jordan JT; Sun W; Hussain SF; DeAngulo G; Prabhu SS; Heimberger AB
    Cancer Immunol Immunother; 2008 Jan; 57(1):123-31. PubMed ID: 17522861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
    Parker R; Weston CJ; Miao Z; Corbett C; Armstrong MJ; Ertl L; Ebsworth K; Walters MJ; Baumart T; Newland D; McMahon J; Zhang P; Singh R; Campbell J; Newsome PN; Charo I; Schall TJ; Adams DH
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G483-G493. PubMed ID: 29420066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice.
    Sennlaub F; Auvynet C; Calippe B; Lavalette S; Poupel L; Hu SJ; Dominguez E; Camelo S; Levy O; Guyon E; Saederup N; Charo IF; Rooijen NV; Nandrot E; Bourges JL; Behar-Cohen F; Sahel JA; Guillonneau X; Raoul W; Combadiere C
    EMBO Mol Med; 2013 Nov; 5(11):1775-93. PubMed ID: 24142887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
    Zannikou M; Duffy JT; Levine RN; Seblani M; Liu Q; Presser A; Arrieta VA; Chen CJ; Sonabend AM; Horbinski CM; Lee-Chang C; Miska J; Lesniak MS; Gottschalk S; Balyasnikova IV
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
    Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
    PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
    Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC
    Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma.
    Shono K; Yamaguchi I; Mizobuchi Y; Kagusa H; Sumi A; Fujihara T; Nakajima K; Kitazato KT; Matsuzaki K; Saya H; Takagi Y
    Sci Rep; 2020 Sep; 10(1):15286. PubMed ID: 32943658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.